pharmaceutical investing Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
pharmaceutical investing MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations
pharmaceutical investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
RUA GOLD Reports Auld Creek Drilling Results Including 2.1m @ 64g/t AuEq Intersected 120m Below the Current Resource, Demonstrating Significant and Open-Ended Depth Potential
Hypromag Achieves Further Technical Milestones as Piloting Ramps Up in Advance of Commercial Rare Earth Magnet Production in The Uk, Germany and USA
Blue Sky Uranium Commences Drill Program to Accelerate Advancement of the Ivana Uranium-Vanadium Project, Argentina
